1. Home
  2. NBIX vs CCK Comparison

NBIX vs CCK Comparison

Compare NBIX & CCK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$149.94

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo Crown Holdings Inc.

CCK

Crown Holdings Inc.

HOLD

Current Price

$101.54

Market Cap

11.5B

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
CCK
Founded
1992
1906
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Containers/Packaging
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
11.5B
IPO Year
1996
2003

Fundamental Metrics

Financial Performance
Metric
NBIX
CCK
Price
$149.94
$101.54
Analyst Decision
Strong Buy
Buy
Analyst Count
22
16
Target Price
$180.91
$121.19
AVG Volume (30 Days)
1.1M
1.1M
Earning Date
05-05-2026
04-27-2026
Dividend Yield
N/A
1.41%
EPS Growth
41.95
79.72
EPS
1.91
1.56
Revenue
$161,626,000.00
$11,665,000,000.00
Revenue This Year
$24.73
$5.17
Revenue Next Year
$13.14
$2.38
P/E Ratio
$77.03
$64.99
Revenue Growth
977.51
N/A
52 Week Low
$115.66
$89.21
52 Week High
$160.18
$116.62

Technical Indicators

Market Signals
Indicator
NBIX
CCK
Relative Strength Index (RSI) 76.44 48.15
Support Level $133.96 $98.25
Resistance Level $158.92 $103.09
Average True Range (ATR) 3.63 2.58
MACD 2.00 -0.05
Stochastic Oscillator 98.20 41.57

Price Performance

Historical Comparison
NBIX
CCK

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About CCK Crown Holdings Inc.

Crown Holdings Inc is a producer of metal packaging. The company manufactures beverage cans, metal food cans, and closures, as well as aerosol cans. With the purchase of Signode, the company also has a presence in a wide variety of protective transport packaging. Although it's headquartered in the United States, the vast majority of Crown's sales come from its operations in Europe, South America, and Southeast Asia.

Share on Social Networks: